This position represents an opportunity for a motivated individual with significant experience in cancer clinical trials of investigational medicinal products to provide efficient regulatory / administrative support, providing expert advice and procedural guidance. The main duties will include managing and scheduling clinical trials and research studies, oversight of regulatory compliance, and training.
1. Oversee each clinical project setup to completion, ensuring the smooth running of the trial and compliance with regulatory and contractual requirements
2. Ensure that trials, once funded, are scheduled optimally to enable the study to proceed according to the timelines
3. Assist with the development of protocols and trial related documents for studies
4. Activities encompass all aspects of the conduct of clinical trials from initial design through to successful delivery and dissemination of CHART provides expertise in trial methodology and management across several key disease areas including cancer & haematological diseases to ensure that the regulatory, legal and quality control aspects of trials are met.
Educated to Degree level and/or extensive experience within the relevant field.
The successful candidate must be organised, highly self-motivated and have excellent communication, interpersonal and computer skills. They will need to manage their time and performance, must be strongly proactive, knowledgeable, and be able to solve complex problems. We are looking for someone willing to work within a team.
5. The opportunity to continue your career at a world-leading institution and be part of our mission to use science for humanity.
6. Develop in your role with access to learning and development opportunities.
7. Benefit from sector-leading salary and remuneration package (including 41 days off a year and generous pension schemes).
8. Gain access to a range of workplace benefits including a flexible working policy from day one, generous family leave packages, on-site leisure facilities and a cycle-to-work scheme.